He backs faster listing of obesity medications on the Pharmaceutical Benefits Scheme and supports incorporating healthy eating education into school curricula.

He highlights lessons from plain cigarette packaging and suggests Australia could lead globally in obesity public health measures by applying similar bold strategies.

The head of Novo Nordisk in Australia urges learning from tobacco control to tackle obesity, calling for clearer food labeling, workplace health checks, and faster access to weight‑loss drugs through the Pharmaceutical Benefits Scheme.

He cautions that while sugary drink taxes could help, they are not a standalone solution and cites Denmark’s fat tax as an example of limited impact.

He argues that graphic health warnings on tobacco have a stronger effect on behavior than taxation alone and implies a similar approach could benefit obesity policy.

He pushes for more legible nutrition labels and questions whether current packaging information aims to actually change choices or merely meet regulatory requirements.

He notes about 13 million Australians are overweight or obese, which harms productivity and strains the health system, urging a society‑wide public health shift to influence habits early.